Twenty-nine patients had a history of type 2 diabetes mellitus before inclusion in the study; therefore, 53 45% individuals included in the study were identified as having type 2 diabetes mellitus T2DM.Metabolic syndrome MetS was diagnosed in 51% of patients according to the amended National Cholesterol Education Program's Adult Treatment Panel III ATP-III.
Por lo tanto, 53 45% individuos incluidos en el estudio fueron identificados como teniendo DMT2. El síndrome metabólico SM fue diagnosticado en un 51% de los pacientes de acuerdo con el National Cholesterol Education Program's Adult Treatment Panillo III ATP-III revisado.
A síndrome metabólica SM foi diagnosticada em 51% dos pacientes de acordo com o National Cholesterol Education Program's Adult Treatment Panel III ATP-III revisado.